Mesenchymal stem cells in joint disease and repair

Nature Reviews Rheumatology

Volumn 9, Issue 10, 2013, Pages 584-594

  Barry, Frank ^a   Murphy, Mary ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM12 PROTEIN; AGGRECANASE 2; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; HYALURONIC ACID; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICULAR CARTILAGE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LABELING; CELL PROLIFERATION; CELL RENEWAL; CELLULAR DISTRIBUTION; CHONDROGENESIS; COLONY FORMING UNIT; DISEASE SEVERITY; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE DEVELOPMENT; NONHUMAN; OSTEOARTHRITIS; OSTEOCYTE; PARACRINE SIGNALING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVIUM; T LYMPHOCYTE ACTIVATION; TISSUE REGENERATION; UPREGULATION;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HUMANS; JOINT DISEASES; MESENCHYMAL STROMAL CELLS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84885319351     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.109     Document Type: Review

References (118)

1. Buckwalter, J. A. & Martin, J. A. Osteoarthritis. Adv. Drug Deliv. Rev. 58, 150-167 (2006).
2. Michaud, C. M. et al. The burden of disease and injury in the United States 1996. Popul. Health Metr. 4, 11 (2006).
3. Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26-35 (2008).
4. Gore, M., Tai, K. S., Sadosky, A., Leslie, D. & Stacey, B. R. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis. J. Med. Econ. 14, 497-507 (2011).
5. McKenna, M. T., Michaud, C. M., Murray, C. J. & Marks, J. S. Assessing the burden of disease in the United States using disability-adjusted life years. Am. J. Prev. Med. 28, 415-423 (2005). (Pubitemid 40719042)
6. Guilak, F. Biomechanical factors in osteoarthritis. Best Pract. Res. Clin. Rheumatol. 25, 815-823 (2011).
7. Findlay, D. M. If good things come from above, do bad things come from below Arthritis Res. Ther. 12, 119 (2010).
8. Goldring, M. B. & Goldring, S. R. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. NY Acad. Sci. 1192, 230-237 (2010).
9. de Lange-Brokaar, B. J. et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage 20, 1484-1499 (2012).
10. Ayral, X., Pickering, E. H., Woodworth, T. G., Mackillop, N. & Dougados, M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis-results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13, 361-367 (2005). (Pubitemid 40631281)
11. Benito, M. J., Veale, D. J., FitzGerald, O., van den Berg, W. B. & Bresnihan, B. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64, 1263-1267 (2005). (Pubitemid 41206240)
12. Buckwalter, J. A., Saltzman, C. & Brown, T. The impact of osteoarthritis: implications for research. Clin. Orthop. Relat. Res. 427 (Suppl.), S6-S15 (2004). (Pubitemid 39362794)
13. Kurtz, S., Ong, K., Lau, E., Mowat, F. & Halpern, M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 89, 780-785 (2007). (Pubitemid 46564282)
14. Friedenstein, A. J., Piatetzky, S. & Petrakova, K. V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16, 381-390 (1966).
15. Friedenstein, A. J., Chailakhjan, R. K. & Lalykina, K. S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3, 393-403 (1970).
16. Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F. & Keiliss-Borok, I. V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331-340 (1974).
17. Friedenstein, A. J. Marrow stromal fibroblasts. Calcif. Tissue Int. 56 (Suppl. 1), S17 (1995).
18. Owen, M. & Friedenstein, A. J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42-60 (1988).
19. Bunnell, B. A., Estes, B. T., Guilak, F. & Gimble, J. M. Differentiation of adipose stem cells. Methods Mol. Biol. 456, 155-171 (2008).
20. Gimble, J. M., Katz, A. J. & Bunnell, B. A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100, 1249-1260 (2007). (Pubitemid 46742916)
21. Meliga, E., Strem, B. M., Duckers, H. J. & Serruys, P. W. Adipose-derived cells. Cell Transplant. 16, 963-970 (2007). (Pubitemid 351448614)
22. Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313 (2008).
23. Troyer, D. L. & Weiss, M. L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26, 591-599 (2008).
24. Weiss, M. L. et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24, 781-792 (2006). (Pubitemid 44464783)
25. Weiss, M. L. & Troyer, D. L. Stem cells in the umbilical cord. Stem Cell Rev. 2, 155-162 (2006). (Pubitemid 46137576)
26. Flynn, A., Barry, F. & O'Brien, T. UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 9, 717-726 (2007). (Pubitemid 350226750)
27. Barry, F. P. & Murphy, J. M. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 36, 568-584 (2004). (Pubitemid 38324589)
28. Delorme, B. & Charbord, P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol. Med. 140, 67-81 (2007).
29. Bianco, P., Robey, P. G. & Simmons, P. J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313-319 (2008). (Pubitemid 351467394)
30. Sacchetti, B. et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324-336 (2007). (Pubitemid 47592917)
31. Tavian, M. et al. The vascular wall as a source of stem cells. Ann. NY Acad. Sci. 1044, 41-50 (2005). (Pubitemid 40967593)
32. Zannettino, A. C. et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J. Cell. Physiol. 214, 413-421 (2008). (Pubitemid 350308998)
33. Caplan, A. I. All MSCs are pericytes Cell Stem Cell 3, 229-230 (2008).
34. Dulauroy, S., Di Carlo, S. E., Langa, F., Eberl, G. & Peduto, L. Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat. Med. 18, 1262-1270 (2012).
35. Kurth, T. B. et al. Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis Rheum. 63, 1289-1300 (2011).
36. De Bari, C., Dell'Accio, F., Tylzanowski, P. & Luyten, F. P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44, 1928-1942 (2001). (Pubitemid 32758241)
37. Karystinou, A. et al. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology (Oxford) 48, 1057-1064 (2009).
38. De Bari, C. et al. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 160, 909-918 (2003). (Pubitemid 36350845)
39. Meng, J. et al. The contribution of human synovial stem cells to skeletal muscle regeneration. Neuromuscul. Disord. 20, 6-15 (2010).
40. Jones, E. A. et al. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum. 58, 1731-1740 (2008). (Pubitemid 351847527)
41. Jones, E. A. et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 50, 817-827 (2004). (Pubitemid 38326182)
42. Sekiya, I. et al. Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J. Orthop. Res. 30, 943-949 (2012).
43. Morito, T. et al. Synovial fluid-derived mesenchymal stem cells increase after intra-articular ligament injury in humans. Rheumatology (Oxford) 47, 1137-1143 (2008). (Pubitemid 352038216)
44. Lee, D. H. et al. Synovial fluid CD34-CD44+ CD90+ mesenchymal stem cell levels are associated with the severity of primary knee osteoarthritis. Osteoarthritis Cartilage 20, 106-109 (2012).
45. Sakaguchi, Y., Sekiya, I., Yagishita, K. & Muneta, T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 52, 2521-2529 (2005). (Pubitemid 41117441)
46. Fan, J., Varshney, R. R., Ren, L., Cai, D. & Wang, D. A. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng. Part B Rev. 15, 75-86 (2009).
47. Khan, W. S., Adesida, A. B., Tew, S. R., Longo, U. G. & Hardingham, T. E. Fat pad-derived mesenchymal stem cells as a potential source for cell-based adipose tissue repair strategies. Cell Prolif. 45, 111-120 (2012).
48. Dowthwaite, G. P. et al. The surface of articular cartilage contains a progenitor cell population. J. Cell Sci. 117, 889-897 (2004). (Pubitemid 38386946)
49. Khan, I. M., Bishop, J. C., Gilbert, S. & Archer, C. W. Clonal chondroprogenitors maintain telomerase activity and Sox9 expression during extended monolayer culture and retain chondrogenic potential. Osteoarthritis Cartilage 17, 518-528 (2009).
50. Williams, R. et al. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS ONE 5, e13246 (2010).
51. Alsalameh, S., Amin, R., Gemba, T. & Lotz, M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 50, 1522-1532 (2004). (Pubitemid 38608074)
52. Grogan, S. P., Miyaki, S., Asahara, H., D'Lima, D. D. & Lotz, M. K. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res. Ther. 11, R85 (2009).
53. Fickert, S., Fiedler, J. & Brenner, R. E. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res. Ther. 6, R422-R432 (2004).
54. Huang, T. F. et al. Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament. Cytotherapy 10, 806-814 (2008).
55. Steinert, A. F. et al. Mesenchymal stem cell characteristics of human anterior cruciate ligament outgrowth cells. Tissue Eng. Part A 17, 1375-1388 (2011).
56. Murray, M. M., Bennett, R., Zhang, X. & Spector, M. Cell outgrowth from the human ACL in vitro: regional variation and response to TGF-1. J. Orthop. Res. 20, 875-880 (2002). (Pubitemid 34823012)
57. Murray, M. M. & Spector, M. The migration of cells from the ruptured human anterior cruciate ligament into collagen-glycosaminoglycan regeneration templates in vitro. Biomaterials 22, 2393-2402 (2001). (Pubitemid 32666230)
58. Cheng, M. T., Yang, H. W., Chen, T. H. & Lee, O. K. Isolation and characterization of multipotent stem cells from human cruciate ligaments. Cell Prolif. 42, 448-460 (2009).
59. Segawa, Y. et al. Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles. J. Orthop. Res. 27, 435-441 (2009).
60. Park, D. et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10, 259-272 (2012).
61. Rinkevich, Y., Lindau, P., Ueno, H., Longaker, M. T. & Weissman, I. L. Germ-layer and lineage-restricted stem/progenitors regenerate the mouse digit tip. Nature 476, 409-413 (2011).
62. Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834 (2010).
63. Flannery, C. R. et al. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and Is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem. Biophys. Res. Commun. 254, 535-541 (1999). (Pubitemid 29290501)
64. Koyama, E. et al. A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Dev. Biol. 316, 62-73 (2008).
65. Lee, C. H. et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 376, 440-448 (2010).
66. Murphy, J. M. et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 46, 704-713 (2002). (Pubitemid 34218142)
67. Scharstuhl, A. et al. Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells 25, 3244-3251 (2007). (Pubitemid 350294450)
68. Im, G. I., Jung, N. H. & Tae, S. K. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng. 12, 527-536 (2006).
69. Coutu, D. L., Francois, M. & Galipeau, J. Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood 117, 6801-6812 (2011).
70. De Bari, C., Dell'Accio, F. & Luyten, F. P. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 44, 85-95 (2001). (Pubitemid 32113122)
71. Jones, E. et al. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum. 62, 1944-1954 (2010).
72. Hiraoka, K., Grogan, S., Olee, T. & Lotz, M. Mesenchymal progenitor cells in adult human articular cartilage. Biorheology 43, 447-454 (2006). (Pubitemid 44221924)
73. Lotz, M. K. et al. Cartilage cell clusters. Arthritis Rheum. 62, 2206-2218 (2010).
74. Koelling, S. et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 4, 324-335 (2009).
75. Blaney Davidson, E. N. et al. Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling. Arthritis Res. Ther. 9, R102 (2007).
76. Guo, X., Thomas, A. & Pirkko, L. A study on abnormal chondrocyte differentiation and abnormal expression of collagen types in articular cartilage from patients with Kaschin-Beck disease [Chinese]. Zhonghua Bing Li Xue Za Zhi 27, 19-22 (1998).
77. Guo, X. et al. Abnormal expression of Col X, PTHrP, TGF-, bFGF, and VEGF in cartilage with Kashin-Beck disease. J. Bone Miner. Metab. 24, 319-328 (2006). (Pubitemid 43992676)
78. Pufe, T., Bartscher, M., Petersen, W., Tillmann, B. & Mentlein, R. Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthritis Cartilage 11, 260-264 (2003). (Pubitemid 36410878)
79. Plaas, A. et al. The relationship between fibrogenic TGF1 signaling in the joint and cartilage degradation in post-injury osteoarthritis. Osteoarthritis Cartilage 19, 1081-1090 (2011).
80. Sandy, J. D., Neame, P. J., Boynton, R. E. & Flannery, C. R. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266, 8683-8685 (1991). (Pubitemid 21906567)
81. Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644-648 (2005). (Pubitemid 40488556)
82. Stanton, H. et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648-652 (2005). (Pubitemid 40488557)
83. Li, J. et al. Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models. J. Orthop. Res. 29, 516-522 (2011).
84. Velasco, J. et al. Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor 1 (TGF 1) signaling. J. Biol. Chem. 286, 26016-26027 (2011).
85. Zhang, Y. W. et al. Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease. Proc. Natl Acad. Sci. USA 102, 11740-11745 (2005).
86. Blaney Davidson, E. N. et al. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum. 56, 4065-4073 (2007). (Pubitemid 350262334)
87. van der Kraan, P. M., Goumans, M. J., Blaney Davidson, E. & ten Dijke, P. Age-dependent alteration of TGF signalling in osteoarthritis. Cell Tissue Res. 347, 257-265 (2012).
88. Anitua, E. et al. Relationship between investigative biomarkers and radiographic grading in patients with knee osteoarthritis. Int. J. Rheumatol. 747432 (2009).
89. Matsumoto, T. et al. Articular cartilage repair with autologous bone marrow mesenchymal cells. J. Cell. Physiol. 225, 291-295 (2010).
90. Wakitani, S. et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 76, 579-592 (1994). (Pubitemid 24154130)
91. Wakitani, S. et al. Repair of large full-thickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel. Tissue Eng. 4, 429-444 (1998). (Pubitemid 28553529)
92. Murphy, J. M., Fink, D. J., Hunziker, E. B. & Barry, F. P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 48, 3464-3474 (2003). (Pubitemid 37531912)
93. Diekman, B. O. et al. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents post-traumatic arthritis. Cell Transplant. http://dx.doi.org/10.3727/096368912X653264.
94. Toghraie, F. et al. Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits. Arch. Iran. Med. 15, 495-499 (2012).
95. Horie, M. et al. Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage 20, 1197-1207 (2012).
96. Sato, M. et al. Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis. Arthritis Res. Ther. 14, R31 (2012).
97. Al Faqeh, H., Nor Hamdan, B. M., Chen, H. C., Aminuddin, B. S. & Ruszymah, B. H. The potential of intra-articular injection of chondrogenic-induced bone marrow stem cells to retard the progression of osteoarthritis in a sheep model. Exp. Gerontol. 47, 458-464 (2012).
98. Guercio, A. et al. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biol. Int. 36, 189-194 (2012).
99. Frisbie, D. D., Kisiday, J. D., Kawcak, C. E., Werpy, N. M. & McIlwraith, C. W. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J. Orthop. Res. 27, 1675-1680 (2009).
100. ter Huurne, M. et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 64, 3604-3613 (2012).
101. Johnson, K. et al. A stem cell-based approach to cartilage repair. Science 336, 717-721 (2012).
102. Wang, Y. et al. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. J. Bone Miner. Res. 20, 1624-1636 (2005). (Pubitemid 41243551)
103. Wotton, S. et al. Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival. Oncogene 27, 5856-5866 (2008).
104. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01586312term=NCT01586312&rank=1 (2012).
105. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01183728term=NCT01183728&rank=1 (2012).
106. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01459640term=NCT01459640&rank=1 (2011).
107. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01504464term=NCT01504464&rank=1 (2012).
108. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01499056term=NCT01499056&rank=1 (2011).
109. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01453738term=NCT01453738&rank=1 (2012).
110. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01436058term=NCT01436058&rank=1 (2011).
111. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01227694term=NCT01227694&rank=1 (2011).
112. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01300598term=NCT01300598&rank=1 (2012).
113. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01041001term=NCT01041001&rank=1 (2012).
114. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01626677term=NCT01041001&rank=2 (2012).
115. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01585857term=NCT01585857&rank=1 (2012).
116. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01088191term=NCT01088191&rank=1 (2012).
117. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01159899term=NCT01159899&rank=1 (2013).
118. Dominici M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006). (Pubitemid 44269669)